Home > News > Newbridge Securities Initiates Coverage on Accelrys
March 14th, 2005
Newbridge Securities Initiates Coverage on Accelrys
Abstract:
J. Andrew Braswell, equity analyst with Newbridge Securities Corporation, has initiated coverage on Accelrys, Inc., with a "Buy" rating and a 12 month price target of $9. Accelrys, Inc. is a major developer and provider of molecular modeling and simulation and informatics software used for research in the life sciences and materials sciences industries, along with general nanotechnology R&D.
Source:
prnewswire
Bookmark:
| Related Links |
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Closing the gaps — MXene-coating filters can enhance performance and reusability February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||